Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Outputs & Impact
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Project
Exploration of an mRNA based nanovaccine platform and immunopeptidomics for the development of more effective tuberculosis vaccines.
Information
Project Team
Organisations
Outputs & Impact
Publications & research data ( 9 )
Sequence simplification of antigen coding IVT mRNA allows accelerated synthetic DNA template generation and epitope immunogenicity validation
Arthur Esprit
Dorien Autaers
Ilke Aernout
Ine Lentacker
Steve Pascolo
Kris Thielemans
Karine Breckpot
Lorenzo Franceschini
A1
Journal Article
in
MOLECULAR THERAPY NUCLEIC ACIDS
2025
Challenges and opportunities in mRNA vaccine development against bacteria
Ilke Aernout
Rein Verbeke
Fabien Henri Thery
Patrick Willems
Uri Elia
Stefaan De Smedt
Rino Rappuoli
Dan Peer
Francis Impens
Ine Lentacker
A1
Journal Article
in
NATURE MICROBIOLOGY
2025
Preclinical toxicological assessment of an α-galactosylceramide-adjuvanted mRNA cancer vaccine in Wistar Han rats and domestic pigs
Sofie Meulewaeter
Margo De Velder
Diethard Reckelbus
Kevin Mwangi
Thomas Ehouarne
Ilke Aernout
Yanou Engelen
Fëllanza Halimi
Isis Van herteryck
Lobke De Bels
et al.
A1
Journal Article
in
MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT
2025
Current state of mRNA vaccine development against Mycobacterium tuberculosis
Ilke Aernout
Rein Verbeke
Stefaan De Smedt
Francis Impens
Ine Lentacker
Bookchapter
in
Trends in mRNA vaccine research
2025
Photoporation of NK-92MI cells with biodegradable polydopamine nanosensitizers as a promising strategy for the generation of engineered NK cell therapies
Charlotte Hinnekens
Aranit Harizaj
Dominika Berdecka
Ilke Aernout
Molood Shariati
Stefanie Peeters
Eva Lion
Stefaan De Smedt
Bart Vandekerckhove
Kevin Braeckmans
et al.
A1
Journal Article
in
APPLIED MATERIALS TODAY
2024
The role of mRNA-galsomes and LNPs in enhancing HIV-specific T cell responses across various lymphoid organs
Sigrid D’haese
Sabine den Roover
Rein Verbeke
Ilke Aernout
Sofie Meulewater
Joëlle Cosyns
Jessy Meert
Sarah Vanbellingen
Thessa Laeremans
Ine Lentacker
et al.
A1
Journal Article
in
MOLECULAR THERAPY NUCLEIC ACIDS
2024
Immunopeptidomics mapping of Listeria monocytogenes T cell epitopes in mice
Adillah Gul
Lecia L. Pewe
Patrick Willems
Rupert Mayer
Fabien Henri Thery
Caroline Asselman
Ilke Aernout
Rein Verbeke
Denzel Eggermont
Laura Van Moortel
et al.
A1
Journal Article
in
MOLECULAR & CELLULAR PROTEOMICS
2024
Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria
Sofie Meulewaeter
Ilke Aernout
Joke Deprez
Yanou Engelen
Margo De Velder
Lorenzo Franceschini
Karine Breckpot
Serge Van Calenbergh
Caroline Asselman
Katie Boucher
et al.
A1
Journal Article
in
JOURNAL OF CONTROLLED RELEASE
2024
Transport by circulating myeloid cells drives liposomal accumulation in inflamed synovium
Joke Deprez
Rein Verbeke
Sofie Meulewaeter
Ilke Aernout
Heleen Dewitte
Tine Decruy
Julie Coudenys
Julie Van Duyse
Gert Van Isterdael
Dan Peer
et al.
A1
Journal Article
in
NATURE NANOTECHNOLOGY
2023
Activities ( 0 )
Results
Impact narratives ( 0 )
Patents ( 0 )